SGLT2 inhibitor downregulates ANGPTL4 to mitigate pathological aging of cardiomyocytes induced by type 2 diabetes.
Wen Y, Zhang X, Liu H, Ye H, Wang R, Ma C, Duo T, Wang J, Yang X, Yu M, Wang Y, Wu L, Zhao Y, Wang L.
Wen Y, et al. Among authors: wang l, wang j, wang y, wang r.
Cardiovasc Diabetol. 2024 Dec 4;23(1):430. doi: 10.1186/s12933-024-02520-8.
Cardiovasc Diabetol. 2024.
PMID: 39633372
Free PMC article.